Harte Hanks (HHS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Q3 2024 revenue increased 1.1% year-over-year to $47.6 million, led by growth in Customer Care and Sales Services, while Marketing and Fulfillment & Logistics declined.
Operating income was $1.9 million, down from $2.9 million in Q3 2023, with a 4.0% margin, impacted by restructuring and higher sales/marketing investment.
Net income was $0.1 million ($0.02 per share), compared to $0.6 million ($0.09 per share) in Q3 2023; nine-month net loss was $27.9 million due to a $37.5 million pension charge.
Project Elevate transformation program is underway, targeting $16 million in cost savings by end of 2025, with $6 million in 2024 and $0.8 million in Q3 restructuring charges.
Strategic focus on sustainable growth, free cash flow optimization, and leveraging data and AI through the new Customer Excellence and Growth division.
Financial highlights
Q3 2024 revenue: $47.6 million (+1.1% YoY); operating income: $1.9 million (down from $2.9 million YoY); net income: $0.1 million ($0.02/share).
Adjusted operating income was $3.1 million, nearly flat year-over-year; adjusted EBITDA was $4.1 million, with a stable margin of 8.7%.
Cash and cash equivalents were $5.9 million as of September 30, 2024, and $9.8 million as of October 31, 2024; $24 million available on credit line.
No outstanding debt; $25 million credit facility remains undrawn.
Capital expenditures for nine months were $3.1 million.
Outlook and guidance
Q4 2024 revenue is expected to decline low to mid-single digits due to customer program changes, but management is confident in expanding the client base and driving sustainable growth.
Project Elevate is on track to deliver $6 million in 2024 savings and $16 million by end of 2025.
Focus remains on growing free cash flow and leveraging new organizational structures.
Latest events from Harte Hanks
- Positive EBITDA and improved net results in FY 2025 despite lower revenue and segment declines.HHS
Q4 202518 Mar 2026 - Q2 net loss of $27.8M from pension charge; Sales Services surged, cash strong, no debt.HHS
Q2 20242 Feb 2026 - Shareholders to vote on board, executive pay, and auditor as company targets growth and innovation.HHS
Proxy Filing2 Dec 2025 - Beneficial ownership update adds Rosenbachs as 26.26% holders for 2025 meeting.HHS
Proxy Filing2 Dec 2025 - Q3 2025 revenue dropped 17% with net loss, but cost controls and new deals support outlook.HHS
Q3 202512 Nov 2025 - Revenue dropped 14.2% but net loss narrowed and EBITDA stayed positive in Q2 2025.HHS
Q2 20258 Aug 2025 - Revenue fell 8.6% to $41.6M, net loss widened, but liquidity and new business remain strong.HHS
Q1 20256 Jun 2025 - Net loss of $30.3M in 2024 driven by pension charges, despite improved cost structure.HHS
Q4 20245 Jun 2025